Amidst the growing infection of the coronavirus, there is continuous good news about its vaccine. According to the Health Ministry and ICMR officials, there are six vaccines in the country, three of which are in the advanced stage. Of the three, Serum India is also ahead of Vaccine Kovishield, Bharat Biotech's Kovaxin, and Zydus Cadila's Zykov D. Volunteers was given a dose of covisiled vaccine in Pune on Wednesday. The dose was installed at Bharti Vidyapeeth Medical College and Hospital in Pune, on which doctors have shared updated information on Thursday.
The Bharti Vidyapeeth Medical College and Hospital has said that the two people who were vaccinated by Oxford University and the Kovid-19 vaccine made by Serum India, have important health standards. A senior doctor from the hospital gave this information on Thursday.
In the second phase of the clinical trial, the first 'shot' of the Kovishield vaccine, produced by Pune's Serum Institute of India (SII), was administered to two persons aged 32 and 48 on Wednesday. An official said that the dose would be repeated after one month.
Dr. Jitendra Oswal, Medical College and Hospital Deputy Director of Medicine said, "Since yesterday our medical team is in touch with both the people and they are both fine. They have no pain, fever, no side effects of the injection, or any further discomfort after vaccination. "
Dr. Oswal said that after being vaccinated on Wednesday, both were monitored for half an hour, only after that, they were allowed to go home. "They were given all the necessary numbers that could be contacted in an emergency," he said. Our medical team is also in constant touch with them. "
The hospital's medical director, Dr. Sanjay Lalwani, said on Wednesday that both individuals would be given one more dose of vaccine after one month and 25 people would be vaccinated in the next seven days.